{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T18:29:21Z","timestamp":1781893761849,"version":"3.54.5"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,7]]},"DOI":"10.7759\/cureus.41505","type":"journal-article","created":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T11:49:30Z","timestamp":1688730570000},"source":"Crossref","is-referenced-by-count":1,"title":["Effects of Methimazole vs Propylthiouracil in Newborns: A Comparative Review"],"prefix":"10.7759","author":[{"given":"Mehak","family":"Bhagat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Purnima","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sindhu Meghana","family":"Sunkara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merin  T","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jimena","family":"Barroso Alverde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sravya R","family":"Mundla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mizrahi Drijanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Jobilal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohit","family":"Lakkimsetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandini","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed","family":"Razzaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zain U","family":"Abdin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishita","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00030.2013","article-title":"Thyroid hormone regulation of metabolism","volume":"94","author":"Mullur R","year":"2014","unstructured":"Mullur R, Liu YY, Brent GA. Thyroid hormone regulation of metabolism. Physiol Rev. 2014, 94:355-82. 10.1152\/physrev.00030.2013","journal-title":"Physiol Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00278-6","article-title":"Hyperthyroidism","volume":"388","author":"De Leo S","year":"2016","unstructured":"De Leo S, Lee SY, Braverman LE. Hyperthyroidism. Lancet. 2016, 388:906-18. 10.1016\/S0140-6736(16)00278-6","journal-title":"Lancet"},{"key":"ref3","article-title":"Hyperthyroidism diagnosis and treatment","volume":"72","author":"Reid JR","year":"2005","unstructured":"Reid JR, Wheeler SF. Hyperthyroidism diagnosis and treatment. Am Fam Physician. 2005, 72:623-30.","journal-title":"Am Fam Physician"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.12659\/msm.881705","article-title":"Hyperthyroidism","volume":"17","author":"Sharma M","year":"2011","unstructured":"Sharma M, Aronow WS, Patel L, Gandhi K, Desai H. Hyperthyroidism. Med Sci Monit. 2011, 17:RA85-91. 10.12659\/msm.881705","journal-title":"Med Sci Monit"},{"key":"ref5","unstructured":"Hyperthyroidism and Pregnancy. Cancer Therapy Advisor. (2019). Accessed. May 17, 2023: https:\/\/www.cancertherapyadvisor.com\/home\/decision-support-in-medicine\/obstetrics-and-gynecology\/hyperthyroidism-and-...."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcte.2019.100190","article-title":"Hyperthyroidism in the pregnant woman: Maternal and fetal aspects","volume":"16","author":"Moleti M","year":"2019","unstructured":"Moleti M, Di Mauro M, Sturniolo G, Russo M, Vermiglio F. Hyperthyroidism in the pregnant woman: Maternal and fetal aspects. J Clin Transl Endocrinol. 2019, 16:100190. 10.1016\/j.jcte.2019.100190","journal-title":"J Clin Transl Endocrinol"},{"key":"ref7","unstructured":"Overactive Thyroid Tied to HTN in Pregnancy. Medpage Today. (2014). Accessed. May 17, 2023: https:\/\/www.medpagetoday.com\/cardiology\/hypertension\/47391."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000009606","article-title":"Impending thyroid storm in a pregnant woman with undiagnosed hyperthyroidism: A case report and literature review","volume":"97","author":"Ma Y","year":"2018","unstructured":"Ma Y, Li H, Liu J, Lin X, Liu H. Impending thyroid storm in a pregnant woman with undiagnosed hyperthyroidism: A case report and literature review. Medicine (Baltimore). 2018, 97:e9606. 10.1097\/MD.0000000000009606","journal-title":"Medicine (Baltimore)"},{"key":"ref9","unstructured":"Global Epidemiology of Hyperthyroidism and Hypothyroidism. IntraMed. (2020). Accessed. May 7, 2023: https:\/\/www.intramed.net\/contenidover.asp?contenidoid=96139."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.endonu.2012.11.006","article-title":"Hyperthyroidism and pregnancy","volume":"60","author":"Gargallo Fern\u00e1ndez M","year":"2013","unstructured":"Gargallo Fern\u00e1ndez M. Hyperthyroidism and pregnancy. Endocrinol Nutr. 2013, 60:535-43. 10.1016\/j.endonu.2012.11.006","journal-title":"Endocrinol Nutr"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-021-00604-z","article-title":"Assessment and treatment of thyroid disorders in pregnancy and the postpartum period","volume":"18","author":"Lee SY","year":"2022","unstructured":"Lee SY, Pearce EN. Assessment and treatment of thyroid disorders in pregnancy and the postpartum period. Nat Rev Endocrinol. 2022, 18:158-71. 10.1038\/s41574-021-00604-z","journal-title":"Nat Rev Endocrinol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(13)70086-X","article-title":"Hyperthyroidism in pregnancy","volume":"1","author":"Cooper DS","year":"2013","unstructured":"Cooper DS, Laurberg P. Hyperthyroidism in pregnancy. Lancet Diabetes Endocrinol. 2013, 1:238-49. 10.1016\/S2213-8587(13)70086-X","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref13","article-title":"Hyperthyroidism in pregnancy","volume":"2015","author":"Nygaard B","year":"2015","unstructured":"Nygaard B. Hyperthyroidism in pregnancy. BMJ Clin Evid. 2015, 2015:0611.","journal-title":"BMJ Clin Evid"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/GRF.0000000000000435","article-title":"Hyperthyroidism during pregnancy: A clinical approach","volume":"62","author":"Cuff RD","year":"2019","unstructured":"Cuff RD. Hyperthyroidism during pregnancy: A clinical approach. Clin Obstet Gynecol. 2019, 62:320-9. 10.1097\/GRF.0000000000000435","journal-title":"Clin Obstet Gynecol"},{"key":"ref15","article-title":"Methimazole","author":"Singh G","year":"2023","unstructured":"Singh G, Correa R. Methimazole. StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2007.06.002","article-title":"Hyperthyroidism","volume":"36","author":"Nayak B","year":"2007","unstructured":"Nayak B, Hodak SP. Hyperthyroidism. Endocrinol Metab Clin North Am. 2007, 36:617-56, v. 10.1016\/j.ecl.2007.06.002","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref17","unstructured":"Methimazole. SafeMedication. (2017). Accessed. June 7, 2023: https:\/\/www.safemedication.com\/drug-library\/a\/6\/8\/2\/4\/a682464."},{"key":"ref18","article-title":"Methimazole","author":"NA","year":"2006","unstructured":"NA. Methimazole. Drugs and Lactation Database (LactMed\u00ae) [Internet]. National Institute of Child Health and Human Development, Bethesda, MD; 2006."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2016.0457","article-title":"2017 guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum","volume":"27","author":"Alexander EK","year":"2017","unstructured":"Alexander EK, Pearce EN, Brent GA, et al.. 2017 guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid. 2017, 27:315-89. 10.1089\/thy.2016.0457","journal-title":"Thyroid"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross DS","year":"2016","unstructured":"Ross DS, Burch HB, Cooper DS, et al.. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016, 26:1343-421. 10.1089\/thy.2016.0229","journal-title":"Thyroid"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-4274","article-title":"Antithyroid drug side effects in the population and in pregnancy","volume":"101","author":"Andersen SL","year":"2016","unstructured":"Andersen SL, Olsen J, Laurberg P. Antithyroid drug side effects in the population and in pregnancy. J Clin Endocrinol Metab. 2016, 101:1606-14. 10.1210\/jc.2015-4274","journal-title":"J Clin Endocrinol Metab"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.32497","article-title":"Choanal atresia associated with maternal hyperthyroidism treated with methimazole: A case-control study","volume":"146A","author":"Barbero P","year":"2008","unstructured":"Barbero P, Valdez R, Rodr\u00edguez H, et al.. Choanal atresia associated with maternal hyperthyroidism treated with methimazole: A case-control study. Am J Med Genet A. 2008, 146A:2390-5. 10.1002\/ajmg.a.32497","journal-title":"Am J Med Genet A"},{"key":"ref23","unstructured":"FDA Drug Safety Communication. New Boxed Warning on Severe Liver Injury With Propylthiouracil. FDA. (2018). Accessed: June 7, 2023: https:\/\/www.fda.gov\/drugs\/postmarket-drug-safety-information-patients-and-providers\/fda-drug-safety-communication-new...."},{"key":"ref24","unstructured":"Propylthiouracil. SafeMedication. (2017). Accessed. June 7, 2023: https:\/\/www.safemedication.com\/drug-library\/a\/6\/8\/2\/4\/a682465."},{"key":"ref25","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(80)91233-7","article-title":"Propylthiouracil in human milk. Revision of a dogma","volume":"315","author":"Kampmann JP","year":"1980","unstructured":"Kampmann JP, Johansen K, Hansen JM, Helweg J. Propylthiouracil in human milk. Revision of a dogma. Lancet. 1980, 315:736-8.","journal-title":"Lancet"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.14654_g","article-title":"Propylthiouracil-induzierte ANCA-assoziierte vaskulopathie","volume":"20","author":"Alotaibi A","year":"2022","unstructured":"Alotaibi A, Alsubaie M, Burmeister A, Menz A, Schneider SW. Propylthiouracil-induzierte ANCA-assoziierte vaskulopathie. J Dtsch Dermatol Ges. 2022, 20:223-6. 10.1111\/ddg.14654_g","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14646","article-title":"Antithyroid drug therapy in pregnancy and risk of congenital anomalies: Systematic review and meta-analysis","volume":"96","author":"Agrawal M","year":"2022","unstructured":"Agrawal M, Lewis S, Premawardhana L, Dayan CM, Taylor PN, Okosieme OE. Antithyroid drug therapy in pregnancy and risk of congenital anomalies: Systematic review and meta-analysis. Clin Endocrinol (Oxf). 2022, 96:857-68. 10.1111\/cen.14646","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.926310","article-title":"Concomitant gallbladder agenesis with methimazole embryopathy","volume":"21","author":"Kato H","year":"2020","unstructured":"Kato H, Mitani Y, Goda T, Yamaue H. Concomitant gallbladder agenesis with methimazole embryopathy. Am J Case Rep. 2020, 21:e926310. 10.12659\/AJCR.926310","journal-title":"Am J Case Rep"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcq248","article-title":"Carbimazole embryopathy: Implications for the choice of antithyroid drugs in pregnancy","volume":"105","author":"Bowman P","year":"2012","unstructured":"Bowman P, Osborne NJ, Sturley R, Vaidya B. Carbimazole embryopathy: Implications for the choice of antithyroid drugs in pregnancy. QJM. 2012, 105:189-93. 10.1093\/qjmed\/hcq248","journal-title":"QJM"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.4103\/0028-3886.27165","article-title":"Aplasia cutis congenita of the scalp: Therapeutic modalities","volume":"54","author":"Shivakumar SK","year":"2006","unstructured":"Shivakumar SK, Dwarakanath S, Swaroop G, Venkataramana NK. Aplasia cutis congenita of the scalp: Therapeutic modalities. Neurol India. 2006, 54:312-3. 10.4103\/0028-3886.27165","journal-title":"Neurol India"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ16-0066","article-title":"Postpartum hypothalamic adrenal insufficiency with remission: A rare case","volume":"64","author":"Akehi Y","year":"2017","unstructured":"Akehi Y, Hashimoto Y, Meren J, Tanabe M, Nomiyama T, Yanase T. Postpartum hypothalamic adrenal insufficiency with remission: A rare case. Endocr J. 2017, 64:157-62. 10.1507\/endocrj.EJ16-0066","journal-title":"Endocr J"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.934417","article-title":"A neonate with a diagnosis of pontocerebellar hypoplasia type 6 treated with biotin and developed biotin interference with laboratory thyroid function tests","volume":"22","author":"Nagafuji M","year":"2021","unstructured":"Nagafuji M, Hitaka D, Iwabuchi A, Miyazono Y, Takada H. A neonate with a diagnosis of pontocerebellar hypoplasia type 6 treated with biotin and developed biotin interference with laboratory thyroid function tests. Am J Case Rep. 2021, 22:e934417. 10.12659\/AJCR.934417","journal-title":"Am J Case Rep"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.24808","article-title":"Gastroschisis due to maternal exposure to carbimazole in a term neonate","volume":"14","author":"Asfour SS","year":"2022","unstructured":"Asfour SS, Al-Mouqdad MM. Gastroschisis due to maternal exposure to carbimazole in a term neonate. Cureus. 2022, 14:e24808. 10.7759\/cureus.24808","journal-title":"Cureus"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.5152\/TurkPediatriArs.2018.5557","article-title":"A rare vascular lesion of newborn: Cutis marmorata telangiectatica congenital","volume":"54","author":"Ergon EY","year":"2019","unstructured":"Ergon EY, \u00c7elik K, \u00c7olak R, \u00d6zdemir SA, Olukman \u00d6, Kundak S, \u00c7alkavur \u015e. A rare vascular lesion of newborn: Cutis marmorata telangiectatica congenital. Turk Pediatri Ars. 2019, 54:133-6. 10.5152\/TurkPediatriArs.2018.5557","journal-title":"Turk Pediatri Ars"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1002\/uog.977","article-title":"Fetal hydrops, associated with maternal propylthiouracil exposure, reversed by intrauterine therapy","volume":"23","author":"Yanai N","year":"2004","unstructured":"Yanai N, Shveiky D. Fetal hydrops, associated with maternal propylthiouracil exposure, reversed by intrauterine therapy. Ultrasound Obstet Gynecol. 2004, 23:198-201. 10.1002\/uog.977","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.ej13-0248","article-title":"Antenatal management of recurrent fetal goitrous hyperthyroidism associated with fetal cardiac failure in a pregnant woman with persistent high levels of thyroid-stimulating hormone receptor antibody after ablative therapy","volume":"60","author":"Matsumoto T","year":"2013","unstructured":"Matsumoto T, Miyakoshi K, Saisho Y, et al.. Antenatal management of recurrent fetal goitrous hyperthyroidism associated with fetal cardiac failure in a pregnant woman with persistent high levels of thyroid-stimulating hormone receptor antibody after ablative therapy. Endocr J. 2013, 60:1281-7. 10.1507\/endocrj.ej13-0248","journal-title":"Endocr J"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.crwh.2018.e00081","article-title":"Fetal hyperthyroidism associated with maternal thyroid autoantibodies: A case report","volume":"20","author":"Kazakou P","year":"2018","unstructured":"Kazakou P, Theodora M, Kanaka-Gantenbein C, et al.. Fetal hyperthyroidism associated with maternal thyroid autoantibodies: A case report. Case Rep Womens Health. 2018, 20:e00081. 10.1016\/j.crwh.2018.e00081","journal-title":"Case Rep Womens Health"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/S1575-0922(09)70556-X","article-title":"Clinical guideline for the diagnosis and treatment of subclinical thyroid dysfunction in pregnancy. Working Group on Subclinical Thyroid Dysfunction of the Spanish Endocrinology Society","volume":"56","author":"Galofr\u00e9 Ferrater JC","year":"2009","unstructured":"Galofr\u00e9 Ferrater JC, Corrales Hern\u00e1ndez JJ, P\u00e9rez Corral B, et al.. Clinical guideline for the diagnosis and treatment of subclinical thyroid dysfunction in pregnancy. Working Group on Subclinical Thyroid Dysfunction of the Spanish Endocrinology Society. Endocrinol Nutr. 2009, 56:85-91. 10.1016\/S1575-0922(09)70556-X","journal-title":"Endocrinol Nutr"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12051811","article-title":"Management of hyperthyroidism during pregnancy: A systematic literature review","volume":"12","author":"Petca A","year":"2023","unstructured":"Petca A, Dimcea DA, Dumitra\u0219cu MC, \u0218andru F, Mehedin\u021bu C, Petca RC. Management of hyperthyroidism during pregnancy: A systematic literature review. J Clin Med. 2023, 12:1811. 10.3390\/jcm12051811","journal-title":"J Clin Med"},{"key":"ref40","unstructured":"National Institute of Diabetes and Digestive and Kidney Diseases. Thyroid Disease & Pregnancy. (2017). Accessed: June 7, 2023: https:\/\/www.niddk.nih.gov\/health-information\/endocrine-diseases\/pregnancy-thyroid-disease."},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1097\/OGX.0000000000000960","article-title":"Thyroid disease in pregnancy: A descriptive review of guidelines","volume":"77","author":"Tsakiridis I","year":"2022","unstructured":"Tsakiridis I, Giouleka S, Kourtis A, Mamopoulos A, Athanasiadis A, Dagklis T. Thyroid disease in pregnancy: A descriptive review of guidelines. Obstet Gynecol Surv. 2022, 77:45-62. 10.1097\/OGX.0000000000000960","journal-title":"Obstet Gynecol Surv"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2021.02.002","article-title":"Subclinical hyperthyroidism: A review of the clinical literature","volume":"27","author":"Tsai K","year":"2021","unstructured":"Tsai K, Leung AM. Subclinical hyperthyroidism: A review of the clinical literature. Endocr Pract. 2021, 27:254-60. 10.1016\/j.eprac.2021.02.002","journal-title":"Endocr Pract"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1038\/ncpendmet0508","article-title":"Therapy insight: Management of Graves' disease during pregnancy","volume":"3","author":"Chan GW","year":"2007","unstructured":"Chan GW, Mandel SJ. Therapy insight: Management of Graves' disease during pregnancy. Nat Clin Pract Endocrinol Metab. 2007, 3:470-8. 10.1038\/ncpendmet0508","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.22037\/ijpr.2020.112892.14005","article-title":"Antithyroid drugs","volume":"18","author":"Abdi H","year":"2019","unstructured":"Abdi H, Amouzegar A, Azizi F. Antithyroid drugs. Iran J Pharm Res. 2019, 18:1-12. 10.22037\/ijpr.2020.112892.14005","journal-title":"Iran J Pharm Res"},{"key":"ref45","article-title":"Propylthiouracil (PTU)","author":"Amisha F","year":"2023","unstructured":"Amisha F, Rehman A. Propylthiouracil (PTU). StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref46","unstructured":"Methimazole Uses, Side Effects & Warnings. Drugs.com. (2023). Accessed. June 7, 2023: https:\/\/www.drugs.com\/mtm\/methimazole.html."},{"key":"ref47","article-title":"Hyperthyroidism in pregnancy","author":"Okosieme OE","year":"2000","unstructured":"Okosieme OE, Lazarus JH. Hyperthyroidism in pregnancy. Endotext [Internet]. Feingold KR, Anawalt B, Blackman MR, et al. (ed): MDText.com, Inc, South Dartmouth, MA; 2000."},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-015-0281-z","article-title":"Pregnancy outcome in women treated with methimazole or propylthiouracil during pregnancy","volume":"38","author":"Gianetti E","year":"2015","unstructured":"Gianetti E, Russo L, Orlandi F, et al.. Pregnancy outcome in women treated with methimazole or propylthiouracil during pregnancy. J Endocrinol Invest. 2015, 38:977-85. 10.1007\/s40618-015-0281-z","journal-title":"J Endocrinol Invest"},{"key":"ref49","article-title":"Hyperthyroidism during pregnancy","volume":"55","author":"Inoue M","year":"2009","unstructured":"Inoue M, Arata N, Koren G, Ito S. Hyperthyroidism during pregnancy. Can Fam Physician. 2009, 55:701-3.","journal-title":"Can Fam Physician"},{"key":"ref50","unstructured":"bumps - best use of medicine in pregnancy. ukits. Use of Carbimazole or Methimazole in Pregnancy. (2019). Accessed. June 7, 2023: https:\/\/www.medicinesinpregnancy.org\/Medicine--pregnancy\/Carbimazole\/."},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.2147\/IJWH.S100987","article-title":"Managing hyperthyroidism in pregnancy: Current perspectives","volume":"8","author":"Andersen SL","year":"2016","unstructured":"Andersen SL, Laurberg P. Managing hyperthyroidism in pregnancy: Current perspectives. Int J Womens Health. 2016, 8:497-504. 10.2147\/IJWH.S100987","journal-title":"Int J Womens Health"},{"key":"ref52","unstructured":"Breastfeeding and Thyroid Problems. Studies and References. KellyMom.com. (2018). Accessed: June 7, 2023: https:\/\/kellymom.com\/health\/mom-health\/thyroid-refs\/."},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1159\/000336595","article-title":"Breastfeeding and antithyroid drugs: A view from within","volume":"1","author":"Karras S","year":"2012","unstructured":"Karras S, Krassas GE. Breastfeeding and antithyroid drugs: A view from within. Eur Thyroid J. 2012, 1:30-3. 10.1159\/000336595","journal-title":"Eur Thyroid J"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvab001","article-title":"Hyperthyroidism in pregnancy and lactation: A different paradigm?","volume":"5","author":"Rind J","year":"2021","unstructured":"Rind J, Mariash CN. Hyperthyroidism in pregnancy and lactation: A different paradigm?. J Endocr Soc. 2021, 5:bvab001. 10.1210\/jendso\/bvab001","journal-title":"J Endocr Soc"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa945","article-title":"Testing, monitoring, and treatment of thyroid dysfunction in pregnancy","volume":"106","author":"Lee SY","year":"2021","unstructured":"Lee SY, Pearce EN. Testing, monitoring, and treatment of thyroid dysfunction in pregnancy. J Clin Endocrinol Metab. 2021, 106:883-92. 10.1210\/clinem\/dgaa945","journal-title":"J Clin Endocrinol Metab"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000197991.64246.9a","article-title":"Subclinical hyperthyroidism and pregnancy outcomes","volume":"107","author":"Casey BM","year":"2006","unstructured":"Casey BM, Dashe JS, Wells CE, McIntire DD, Leveno KJ, Cunningham FG. Subclinical hyperthyroidism and pregnancy outcomes. Obstet Gynecol. 2006, 107:337-41. 10.1097\/01.AOG.0000197991.64246.9a","journal-title":"Obstet Gynecol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.2174\/138920111795470895","article-title":"The optimal treatment of thyroid gland function disturbances during pregnancy","volume":"12","author":"Drews K","year":"2011","unstructured":"Drews K, Seremak-Mrozikiewicz A. The optimal treatment of thyroid gland function disturbances during pregnancy. Curr Pharm Biotechnol. 2011, 12:774-80. 10.2174\/138920111795470895","journal-title":"Curr Pharm Biotechnol"},{"key":"ref58","article-title":"Influence of screening and intervention of hyperthyroidism on pregnancy outcome","volume":"21","author":"Wang Y","year":"2017","unstructured":"Wang Y, Sun XL, Wang CL, Zhang HY. Influence of screening and intervention of hyperthyroidism on pregnancy outcome. Eur Rev Med Pharmacol Sci. 2017, 21:1932-7.","journal-title":"Eur Rev Med Pharmacol Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/165244-effects-of-methimazole-vs-propylthiouracil-in-newborns-a-comparative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:02:07Z","timestamp":1707508927000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/165244-effects-of-methimazole-vs-propylthiouracil-in-newborns-a-comparative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,7]]},"references-count":58,"URL":"https:\/\/doi.org\/10.7759\/cureus.41505","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,7]]}}}